Showing results (91-100 of 153) with videos related to

Sort By:
Pageof 16
The Journal of Clinical Endocrinology and Metabolism|December 31, 2005
Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' diseaseM J Simmonds, J M Heward, J Carr-Smith, et al.
Thyroid : Official Journal of the American Thyroid Association|March 10, 2010
Confirmation of association of chromosome 5q31-33 with United Kingdom Caucasian Graves' diseaseMatthew J Simmonds, Kadija Yesmin, Paul R Newby, et al.
The American Surgeon|August 29, 2020
Right Patient, Right Place, Right Time : Field Triage and Transfer to Level I Trauma CentersBenjamin L Gough, Matthew D Painter, Autumn L Hoffman, et al.
Development, Growth & Differentiation|October 24, 1997
Evidence for cell surface and internal phospholipase activity in ascidian eggsC A Goode, A J Gamboa-Pinto, R Cruz, et al.
Autoimmunity|October 23, 2004
Polymorphisms of interleukin 4 receptor gene and interleukin 10 gene are not associated with Graves' disease in the UKKaren F Tait, Ratnasingam Nithiyananthan, Joanne M Heward, et al.
The American Surgeon|July 21, 2020
Right Patient, Right Place, Right Time: Field Triage and Transfer to Level I Trauma CentersBenjamin L Gough, Matthew D Painter, Autumn L Hoffman, et al.
FEMS Microbiology Ecology|May 29, 2013
Functional gene array-based analysis of microbial communities in heavy metals-contaminated lake sedimentsSanghoon Kang, Joy D Van Nostrand, Heidi L Gough, et al.
Clinical Endocrinology|July 15, 2010
Association of Fc receptor-like 5 (FCRL5) with Graves' disease is secondary to the effect of FCRL3Matthew J Simmonds, Oliver J Brand, Jeffrey C Barrett, et al.
Clinical Endocrinology|July 5, 2007
Preliminary evidence for interaction of PTPN12 polymorphism with TSHR genotype and association with Graves' ophthalmopathyA A Syed, M J Simmonds, O J Brand, et al.
Diabetes, Obesity & Metabolism|September 8, 2015
Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetesH W Rodbard, J B Buse, V Woo, et al.
Pageof 16